Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on July 27, 2021. The report primarily addresses the announcement of consolidated financial results for the fourth quarter and full fiscal year ended May 30, 2021, as well as corporate governance changes.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing the detailed financial results for the fourth quarter and full fiscal year 2021. However, the text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These figures must be obtained from the referenced press release.
Material Changes and Corporate Events
- Board Resignation: Patrick D. Walsh resigned from the Board of Directors effective July 27, 2021. The resignation was not due to any disagreement with the Company regarding operations, policies, or accounting principles. The Board size was reduced to 10 members.
- Executive Compensation: The Board approved discretionary annual bonuses for named executive officers, totaling approximately $488,466. These bonuses were granted despite the Company and its subsidiary, Curation Foods, Inc., failing to achieve the threshold performance goals for the 2021 bonus program.
Discretionary Bonus Details
| Executive Officer | Title | Bonus Amount |
|---|---|---|
| Albert Bolles | President and CEO | $319,300 |
| John Morberg | Chief Financial Officer | $85,416 |
| Tim Burgess | Curation Foods – SVP Supply Chain | $83,750 |
Note: Mr. Morberg's bonus was pro-rated for his partial year of employment. Each bonus represented 50% of the executive's target bonus.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future outlook, or a discussion of risks and contingencies beyond the standard legal disclaimers regarding the press release. The text notes that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, EPS) by reviewing Exhibit 99.1 (Press Release dated July 28, 2021), as they are not listed in this 8-K text.
- Confirm the rationale for awarding discretionary bonuses despite the failure to meet threshold performance goals under the 2021 bonus program.
- Monitor the Company's plans to fill the vacancy on the Board of Directors left by Patrick D. Walsh's resignation.
- Clarify the discrepancy between the metadata company name (Lifecore Biomedical) and the actual registrant (Landec Corporation).